181 related articles for article (PubMed ID: 11221855)
41. Down-regulation of prostasin serine protease: a potential invasion suppressor in prostate cancer.
Chen LM; Hodge GB; Guarda LA; Welch JL; Greenberg NM; Chai KX
Prostate; 2001 Jul; 48(2):93-103. PubMed ID: 11433419
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
[TBL] [Abstract][Full Text] [Related]
43. Immunoreactivity to caspase-3, caspase-7, caspase-8, and caspase-9 forms is frequently lost in human prostate tumors.
RodrÃguez-Berriguete G; Galvis L; Fraile B; de Bethencourt FR; MartÃnez-Onsurbe P; Olmedilla G; Paniagua R; Royuela M
Hum Pathol; 2012 Feb; 43(2):229-37. PubMed ID: 21802116
[TBL] [Abstract][Full Text] [Related]
44. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
[TBL] [Abstract][Full Text] [Related]
45. [Expression and clinical significance of antiapoptosis gene XIAP in prostate cancer].
Liu J; Li M; Xia S
Zhonghua Nan Ke Xue; 2004 Nov; 10(11):832-5. PubMed ID: 15595685
[TBL] [Abstract][Full Text] [Related]
46. Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions.
Rehman I; Azzouzi AR; Cross SS; Deloulme JC; Catto JW; Wylde N; Larre S; Champigneuille J; Hamdy FC
Hum Pathol; 2004 Nov; 35(11):1385-91. PubMed ID: 15668896
[TBL] [Abstract][Full Text] [Related]
47. Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits growth of PC-3 human prostate cancer xenografts in vivo.
Srivastava SK; Xiao D; Lew KL; Hershberger P; Kokkinakis DM; Johnson CS; Trump DL; Singh SV
Carcinogenesis; 2003 Oct; 24(10):1665-70. PubMed ID: 12896904
[TBL] [Abstract][Full Text] [Related]
48. Caspase 3 in breast cancer.
O'Donovan N; Crown J; Stunell H; Hill AD; McDermott E; O'Higgins N; Duffy MJ
Clin Cancer Res; 2003 Feb; 9(2):738-42. PubMed ID: 12576443
[TBL] [Abstract][Full Text] [Related]
49. Alpha1-adrenoceptor antagonists radiosensitize prostate cancer cells via apoptosis induction.
Cuellar DC; Rhee J; Kyprianou N
Anticancer Res; 2002; 22(3):1673-9. PubMed ID: 12168853
[TBL] [Abstract][Full Text] [Related]
50. Loss of uteroglobin expression in prostate cancer: relationship to advancing grade.
Weeraratna AT; Cajigas JA; Schwartz A; Enquist EG; Manyak MJ; Patierno SR
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2295-300. PubMed ID: 9815627
[TBL] [Abstract][Full Text] [Related]
51. WAVE3 is associated with invasiveness in prostate cancer cells.
Fernando HS; Sanders AJ; Kynaston HG; Jiang WG
Urol Oncol; 2010; 28(3):320-7. PubMed ID: 19395286
[TBL] [Abstract][Full Text] [Related]
52. There are multiple forms of glyceraldehyde-3-phosphate dehydrogenase in prostate cancer cells and normal prostate tissue.
Epner DE; Coffey DS
Prostate; 1996 Jun; 28(6):372-8. PubMed ID: 8650074
[TBL] [Abstract][Full Text] [Related]
53. Reduced expression of ICE/caspase1 and CPP32/caspase3 in human hepatocellular carcinoma.
Fujikawa K; Shiraki K; Sugimoto K; Ito T; Yamanaka T; Takase K; Nakano T
Anticancer Res; 2000; 20(3B):1927-32. PubMed ID: 10928128
[TBL] [Abstract][Full Text] [Related]
54. Knockdown of zinc finger protein X-linked inhibits prostate cancer cell proliferation and induces apoptosis by activating caspase-3 and caspase-9.
Jiang H; Zhang L; Liu J; Chen Z; Na R; Ding G; Zhang H; Ding Q
Cancer Gene Ther; 2012 Oct; 19(10):684-9. PubMed ID: 22898899
[TBL] [Abstract][Full Text] [Related]
55. CD44 Expression in Benign and Neoplastic Human Prostates.
Dhir R; Gau JT; Krill D; Bastacky S; Bahnson RR; Cooper DL; Becich MJ
Mol Diagn; 1997 Sep; 2(3):197-204. PubMed ID: 10462610
[TBL] [Abstract][Full Text] [Related]
56. Synthesis of procaspases-3 and -7 during apoptosis in prostate cancer cells.
Bowen C; Voeller HJ; Kikly K; Gelmann EP
Cell Death Differ; 1999 May; 6(5):394-401. PubMed ID: 10381629
[TBL] [Abstract][Full Text] [Related]
57. Signaling for the caspases: their role in prostate cell apoptosis.
Coffey RN; Watson RW; Fitzpatrick JM
J Urol; 2001 Jan; 165(1):5-14. PubMed ID: 11125352
[TBL] [Abstract][Full Text] [Related]
58. Mutational analysis of caspase genes in prostate carcinomas.
Kim MS; Park SW; Kim YR; Lee JY; Lim HW; Song SY; Yoo NJ; Lee SH
APMIS; 2010 Apr; 118(4):308-12. PubMed ID: 20402676
[TBL] [Abstract][Full Text] [Related]
59. MUC1 Expression in Prostate Carcinoma: Correlation with Grade and Stage.
Kirschenbaum A; Itzkowitz SH; Wang JP; Yao S; Eliashvili M; Levine AC
Mol Urol; 1999; 3(3):163-168. PubMed ID: 10851319
[TBL] [Abstract][Full Text] [Related]
60. Evidence for the differential expression of a variant EGF receptor protein in human prostate cancer.
Olapade-Olaopa EO; Moscatello DK; MacKay EH; Horsburgh T; Sandhu DP; Terry TR; Wong AJ; Habib FK
Br J Cancer; 2000 Jan; 82(1):186-94. PubMed ID: 10638988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
